February 12 - 13, 2015, president/chief scientific officer Dr. Lu Xianping of Shenzhen CHIPSCREEN BiosesCIENCES was invited to attend the frontier seminar on tumor biology and new drug development held at the HongKong polytechnic University. He gave a speech on the theme " Discovery of an Orally Active Subtype-Selective HDAC Inhibitor, Chidamide, as an Epigenetic Modulator for Cancer Treatment " and shared the discovery journey and latest research progress of CHIPSCREEN BiosesCIENCES epigenetic antitumor drug Chidamide in Shenzhen with the participating experts.